Max Healthcare Institute Limited (MHIL) reported a robust Q1 FY27 performance, with Gross Revenue increasing by 16% YoY to ₹2,982 crore. Network Operating EBITDA saw a 15% YoY growth, reaching ₹704 crore. The company also highlighted strategic acquisitions, including Kalinga Hospital Limited and Yerawada Properties Private Limited, reinforcing its expansion strategy and market position.
Max Healthcare Reports Strong Q1 FY27 Financials
Max Healthcare Institute Limited (MHIL) has announced its financial results for the first quarter ended June 30, 2026, showcasing significant growth across key metrics. Gross Revenue for the network surged by 16% year-over-year (YoY) to ₹2,982 crore, primarily driven by an increase in occupied bed days. This marks a strong start to the fiscal year, reflecting the company’s expanding operational capacity and market demand.
Key Financial Highlights
- Network Gross Revenue: ₹2,982 crore, a 16% YoY growth.
- Network Operating EBITDA: ₹704 crore, a 15% YoY growth.
- EBITDA Margin: Stood at 24.8%, compared to 24.9% in Q1 FY26.
- Profit After Tax (PAT): Increased to ₹357 crore from ₹345 crore in Q1 FY26.
- Free Cash from Operations: Recorded at ₹397 crore.
Strategic Acquisitions and Capacity Expansion
The company has made significant strides in its strategic expansion through acquisitions. On May 18, 2026, MHIL completed the acquisition of a controlling stake (58.28%) in Kalinga Hospital Limited (KHL) for approximately ₹298 crore. KHL operates a 250-bed multispeciality hospital in Bhubaneswar, Odisha. Further, on June 30, 2026, the company acquired all outstanding Class A equity shares of Yerawada Properties Private Limited (YPPL), representing 100% voting rights and approximately 50.22% of the economic interest. Preliminary approval has been received for a proposed 450-bed hospital in Pune on land owned by YPPL.
In terms of organic growth, 202 beds in the brownfield tower of Max Smart Super Speciality Hospital have become operational. The remaining 198 beds are expected to be handed over in Q2 FY27. Additionally, the Board approved a capital expenditure of ₹425 crore for a brownfield tower at MSSH Vaishali, which will add 202 beds.
Other Business Updates
Max Lab reported a gross revenue of ₹58 crore, a 20% YoY growth, with services available in over 60 cities. Max@Home generated revenue of ₹78 crore, a 32% YoY growth, driven by various health and wellness services. The company also emphasized its commitment to social responsibility by providing free treatment to 54,186 OPD and 1,933 IPD patients from economically weaker sections.
Medical Education Initiative
The Board has granted in-principle approval to explore opportunities in medical education and establish medical colleges, aligning with proposed regulatory changes by the National Medical Commission.
Source: BSE
